Sumer Jacquelyn L
- SEC CIK
- 0001844824
In the past year, 3 open-market sale filings worth $136.7K and no purchases.
Current role at each company
- CGEM Cullinan Therapeutics, Inc.Chief Legal Officeras of Jul 2, 2026
- GNCA Genocea Biosciences, Inc.CHIEF LEGAL & COMPLIANCE OFFas of Jun 2, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $136.7K
- 3 filings
- Net
- −$136.7K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Sumer Jacquelyn L as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
CGEM Cullinan Therapeutics, Inc.
Chief Legal Officer11 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 25, 2026 (view filing) | Feb 24 | 1 day | Sumer Jacquelyn LChief Legal Officer | SSale | −3.60K | $14.47 | −$52.1K | −2.7%128.1K after | |
| Feb 23, 2026 (view filing) | Feb 20 | 3 days | Sumer Jacquelyn LChief Legal Officer | SSale | −3.74K | $13.62 | −$51.0K | −2.8%131.7K after | |
| Dec 19, 2025 (view filing) | Dec 18 | 1 day | Sumer Jacquelyn LChief Legal Officer | SSale | −3.48K | $9.67 | −$33.7K | −2.5%135.4K after | |
| Feb 27, 2025 (view filing) | Feb 25 | 2 days | Sumer Jacquelyn LChief Legal Officer | SSale | −3.76K | $8.53 | −$32.0K | −2.7%136.9K after | |
| Dec 20, 2024 (view filing) | Dec 18 | 2 days | Sumer Jacquelyn LChief Legal Officer | SSale | −3.48K | $11.41 | −$39.7K | −3.7%90.7K after | |
| Dec 22, 2023 (view filing) | Dec 21 | 1 day | Sumer Jacquelyn LChief Legal Officer | SSale | −1.40K | $8.50 | −$11.9K | −3.1%44.1K after | |
| Dec 20, 2023 (view filing) | Dec 18 | 2 days | Sumer Jacquelyn LChief Legal Officer | SSale | −290 | $8.22 | −$2.38K | −0.6%45.5K after | |
| Jun 21, 2023 (view filing) | Jun 20 | 1 day | Sumer Jacquelyn LChief Legal Officer | SSale | −291 | $12.94 | −$3.77K | −0.6%45.8K after | |
| May 19, 2023 (view filing) | May 18 | 1 day | Sumer Jacquelyn LChief Legal Officer | SSale | −291 | $8.76 | −$2.55K | −0.6%46.1K after | |
| Apr 20, 2023 (view filing) | Apr 18 | 2 days | Sumer Jacquelyn LChief Legal Officer | SSale | −290 | $10.71 | −$3.11K | −0.6%46.4K after |
GNCA Genocea Biosciences, Inc.
CHIEF LEGAL & COMPLIANCE OFF1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 2, 2022 (view filing)4:32 PM ET | Jun 1 | 1 day | Sumer Jacquelyn LCHIEF LEGAL & COMPLIANCE OFF | SSale | −2.50K | $0.0601 | −$150.25 | −5.5%43.0K after |